75 related articles for article (PubMed ID: 18362630)
1. Changing paradigm in the management of hepatocellular carcinoma improves the survival benefit of early detection by screening.
Chan AC; Poon RT; Ng KK; Lo CM; Fan ST; Wong J
Ann Surg; 2008 Apr; 247(4):666-73. PubMed ID: 18362630
[TBL] [Abstract][Full Text] [Related]
2. Reply: New confounders emerging with new evidence regarding reduced HCC and improved survival.
Jeng WJ; Chien RN; Liaw YF
Hepatology; 2024 Jun; ():. PubMed ID: 38836640
[No Abstract] [Full Text] [Related]
3. 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma.
Korean Liver Cancer Association (KLCA) and National Cancer Center (NCC) Korea
J Liver Cancer; 2023 Mar; 23(1):1-120. PubMed ID: 37384024
[TBL] [Abstract][Full Text] [Related]
4. Fatal, non-fatal burden of cancer in the elderly in China, 2005-2016: a nationwide registry-based study.
Ma ZR; Lin KQ; Guo H; Yang KY; Cao M; Song X; Jia HM; Hu YH; Yan YZ
BMC Public Health; 2023 May; 23(1):877. PubMed ID: 37173657
[TBL] [Abstract][Full Text] [Related]
5. 2022 KLCA-NCC Korea Practice Guidelines for the Management of Hepatocellular Carcinoma.
Korean Liver Cancer Association (KLCA) and National Cancer Center (NCC) Korea
Korean J Radiol; 2022 Dec; 23(12):1126-1240. PubMed ID: 36447411
[TBL] [Abstract][Full Text] [Related]
6. 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma.
Korean Liver Cancer Association (KLCA) and National Cancer Center (NCC) Korea
Clin Mol Hepatol; 2022 Oct; 28(4):583-705. PubMed ID: 36263666
[TBL] [Abstract][Full Text] [Related]
7. Influence of AFP on surgical outcomes in non-B non-C patients with curative resection for hepatocellular carcinoma.
Tan XP; Zhou K; Zeng QL; Yuan YF; Chen W
Clin Exp Med; 2023 Feb; 23(1):107-115. PubMed ID: 35293607
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes of surgical resection versus radiofrequency ablation in very-early-stage hepatocellular carcinoma: a propensity score matching analysis.
Li YC; Chen PH; Yeh JH; Hsiao P; Lo GH; Tan T; Cheng PN; Lin HY; Chen YS; Hsieh KC; Hsieh PM; Lin CW
BMC Gastroenterol; 2021 Nov; 21(1):418. PubMed ID: 34749663
[TBL] [Abstract][Full Text] [Related]
9. Extracellular vesicles as a new hope for diagnosis and therapeutic intervention for hepatocellular carcinoma.
Nimitrungtawee N; Inmutto N; Chattipakorn SC; Chattipakorn N
Cancer Med; 2021 Dec; 10(23):8253-8271. PubMed ID: 34708589
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant transarterial chemotherapy for margin-positive resection of hepatocellular carcinoma-a propensity score matched analysis.
Fok AJ; She WH; Ma KW; Tsang SHY; Dai WC; Chan ACY; Lo CM; Cheung TT
Langenbecks Arch Surg; 2022 Feb; 407(1):245-257. PubMed ID: 34406489
[TBL] [Abstract][Full Text] [Related]
11. Prognosis Factors of Young Patients Undergoing Curative Resection for Hepatitis B Virus-Related Hepatocellular Carcinoma: A Multicenter Study.
Zeng J; Lin K; Liu H; Huang Y; Guo P; Zeng Y; Zeng J; Liu J
Cancer Manag Res; 2020; 12():6597-6606. PubMed ID: 32848453
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Survival Outcomes After Liver Resection for Binodular Hepatocellular Carcinoma: A Multicenter Cohort Study.
Wang MD; Li C; Li J; Zhang WG; Jiang WQ; Yu JJ; Xing H; Wu H; Han J; Li ZL; Xu XF; Chen TH; Zhou YH; Gu WM; Wang H; Zeng YY; Zhang YM; Pawlik TM; Lau WY; Wu MC; Yang JM; Shen F; Yang T
Oncologist; 2019 Aug; 24(8):e730-e739. PubMed ID: 31127021
[TBL] [Abstract][Full Text] [Related]
13. Optimizing hepatectomy for hepatocellular carcinoma in Asia-patient selection and special considerations.
Kotewall CN; Cheung TT
Transl Gastroenterol Hepatol; 2018; 3():75. PubMed ID: 30505962
[TBL] [Abstract][Full Text] [Related]
14. Risk Factors, Patterns, and Outcomes of Late Recurrence After Liver Resection for Hepatocellular Carcinoma: A Multicenter Study From China.
Xu XF; Xing H; Han J; Li ZL; Lau WY; Zhou YH; Gu WM; Wang H; Chen TH; Zeng YY; Li C; Wu MC; Shen F; Yang T
JAMA Surg; 2019 Mar; 154(3):209-217. PubMed ID: 30422241
[TBL] [Abstract][Full Text] [Related]
15. Survival following hospitalization with hepatocellular carcinoma among people notified with hepatitis B or C virus in Australia (2000-2014).
Waziry R; Grebely J; Amin J; Alavi M; Hajarizadeh B; George J; Matthews GV; Law M; Dore GJ
Hepatol Commun; 2017 Oct; 1(8):736-747. PubMed ID: 29404490
[TBL] [Abstract][Full Text] [Related]
16. Sub-classification of Advanced-Stage Hepatocellular Carcinoma: A Cohort Study Including 612 Patients Treated with Sorafenib.
Yoo JJ; Chung GE; Lee JH; Nam JY; Chang Y; Lee JM; Lee DH; Kim HY; Cho EJ; Yu SJ; Kim YJ; Yoon JH;
Cancer Res Treat; 2018 Apr; 50(2):366-373. PubMed ID: 28521494
[TBL] [Abstract][Full Text] [Related]
17. The importance of a multidisciplinary approach to hepatocellular carcinoma.
Siddique O; Yoo ER; Perumpail RB; Perumpail BJ; Liu A; Cholankeril G; Ahmed A
J Multidiscip Healthc; 2017; 10():95-100. PubMed ID: 28360525
[TBL] [Abstract][Full Text] [Related]
18. Comparable Outcomes of Ultrasound versus Computed Tomography in the Guidance of Radiofrequency Ablation for Hepatocellular Carcinoma.
Lee LH; Hwang JI; Cheng YC; Wu CY; Lee SW; Yang SS; Yeh HZ; Chang CS; Lee TY
PLoS One; 2017; 12(1):e0169655. PubMed ID: 28068369
[TBL] [Abstract][Full Text] [Related]
19. Semiannual Imaging Surveillance Is Associated with Better Survival in Patients with Non-B, Non-C Hepatocellular Carcinoma.
Shindo K; Maekawa S; Komatsu N; Tatsumi A; Miura M; Sato M; Suzuki Y; Matsuda S; Muraoka M; Amemiya F; Fukasawa M; Yamaguchi T; Nakayama Y; Uetake T; Inoue T; Sakamoto M; Sato T; Enomoto N
Mediators Inflamm; 2015; 2015():687484. PubMed ID: 26494948
[TBL] [Abstract][Full Text] [Related]
20. Transarterial chemoembolization in hepatocellular carcinoma treatment: Barcelona clinic liver cancer staging system.
Han K; Kim JH
World J Gastroenterol; 2015 Sep; 21(36):10327-35. PubMed ID: 26420959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
